Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Medical pioneers Hims & Hers Health (HIMS) and Novo Nordisk (NVO) are making headlines this week after announcing a partnership to expand obesity care in the telehealth space.

Shares of Hims & Hers Health, Inc. (HIMS) marked their best session in nearly three months on Tuesday, surging over 23% after ...

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...

We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take a look at ...

CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

For most states, the top hairstyle for men is a fade, followed closely by a buzz cut (two good styles if you’ve got thinning ...

Great hair is a growing aspiration among Americans. Having "better hair" ranks higher on people's top goals for 2025 than ...

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy ® (semaglutide).